Home About Us Contact Us

 

Table of Content - Volume 6 Issue 3 - June 2017


A study of level of glycosylated hemoglobin in patients of diabetes mellitus at tertiary health care centre

 

Dilip Pandurang Patil

 

Assistant Professor, Department of Medicine, Krishna institute of Medical sciences " Deemed To Be University" Karad

Dist_ Satara-415539, Maharashtra, INDIA.

Email: patilhospitalkarad@gmail.com

 

Abstract              Background: The glycosylated haemoglobin (HbA1c) test has been the most widely accepted, reliable biomarker for evaluating long term glycaemic control in patients with diabetes mellitus (DM). Aims and Objectives: To Study level of glycosylated hemoglobin in patients of diabetes mellitus at tertiary health care centre. Methodology: This prospective study was undertaken at Krishna Hospital and Medial research Centre, Karad. One hundred patients of Diabetes Mellitus admitted to hospital during an eighteen month period from 1st July 1977 to 31st December 1998 were included in the study. The glycosylated hemoglobin was estimated by kit available in our hospital. We considered HbA1C (%) less than 8 –Good, 8.1-9.0-Fair, 9.1-11-Poor, >11-Bad. Result: In our study we have seen that The majority of the patients were in the age group of 51-60 were 34%, 61-70 were 27%, followed by 41-50 were 18%, 31-40 were 7%, 71-80% were 6%, 21-30 were 4%, >80 and <20 were 2%. The IDDM patients were 28% and NIDDM were 72%. The majority of the patients were with HbA1C% >11 (Bad) were 41%, 9.1-11.0 (Poor)-19%, 8.1-9.0 (Fair)-16%, <8 (Good)-24%. Conclusion: It can be concluded from our study that the majority of the patients were in the age group of 51-60, the majority of the patents were NIDDM and majority were associated with > 11 HbA1C%.

Key Wrds: Glycosylated hemoglobin (HbA1C), IDDM (Insulin Dependant Diabetes Mellitus), NIDDM (Non-insulin Dependant Diabetes Mellitus).